(RGC) Regencell Bioscience - Performance 0% in 12m
RGC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
38.90%
#12 in Peer-Group
Rel. Strength
41.23%
#4474 in Stock-Universe
Total Return 12m
0.00%
#59 in Peer-Group
Total Return 5y
5567.62%
#1 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 877.00 USD |
| 52 Week Low | 3.20 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 78.63 |
| Buy/Sell Signal +-5 | -0.59 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RGC (0%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.2 | 13.8 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.1 | 14.3 | 0.59 | -62.1% | -19.3% |
Performance Comparison: RGC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RGC
| Total Return (including Dividends) | RGC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 48.03% | 7.76% | 1.11% |
| 3 Months | 3116.76% | -5.31% | 5.58% |
| 12 Months | 0.00% | -7.58% | 10.51% |
| 5 Years | 5567.62% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | RGC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 66.8% | 84.2% | 69.9% |
| 3 Months | 84.3% | -2.8% | 69.3% |
| 12 Months | 50.5% | -77.8% | 43.2% |
| 5 Years | -45% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #2 | 37.37% | 46.41% |
| 3 Month | #2 | 3297.02% | 2946.75% |
| 12 Month | #59 | 8.20% | -9.51% |
| 5 Years | #2 | 8423.70% | 3781.09% |
FAQs
Does Regencell Bioscience (RGC) outperform the market?
Yes,
over the last 12 months RGC made 0.00%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months RGC made 3116.76%, while XBI made -5.31%.
Performance Comparison RGC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RGC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -6.6% | 46.9% | 1% | -11% |
| US NASDAQ 100 | QQQ | -6.3% | 46.6% | 1.8% | -9% |
| German DAX 40 | DAX | -4.4% | 48.8% | -15.4% | -29% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.3% | 49% | -0.8% | -12% |
| Hongkong Hang Seng | HSI | -7.1% | 43% | -18% | -27% |
| India NIFTY 50 | INDA | -4.8% | 49.4% | 2% | 1% |
| Brasil Bovespa | EWZ | -8.9% | 47.6% | -19.2% | -9% |
RGC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.2% | 46.6% | -1.8% | -23% |
| Consumer Discretionary | XLY | -6% | 49.8% | 10.9% | -18% |
| Consumer Staples | XLP | -6.3% | 48.3% | -0.5% | -7% |
| Energy | XLE | -12.4% | 45.1% | -2.6% | -3% |
| Financial | XLF | -5% | 50.6% | -1.8% | -24% |
| Health Care | XLV | -8.5% | 43.7% | 1.5% | 5% |
| Industrial | XLI | -5.5% | 47.7% | -4.6% | -18% |
| Materials | XLB | -5.9% | 46.6% | 0.2% | 1% |
| Real Estate | XLRE | -7.1% | 47.1% | 0% | -13% |
| Technology | XLK | -6.9% | 46% | 0.6% | -4% |
| Utilities | XLU | -7.9% | 47.5% | -7.4% | -21% |
| Aerospace & Defense | XAR | -5.6% | 42.3% | -15.9% | -43% |
| Biotech | XBI | -6.2% | 40.3% | 11.8% | 8% |
| Homebuilder | XHB | -5% | 53.1% | 16.4% | 9% |
| Retail | XRT | -2.6% | 48.2% | 9% | -1% |
RGC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -18.4% | 29.3% | -8.85% | -3% |
| Natural Gas | UNG | -5.8% | 50.7% | -17.3% | 15% |
| Gold | GLD | -10.2% | 41.8% | -29.2% | -47% |
| Silver | SLV | -5.8% | 36.7% | -18.6% | -22% |
| Copper | CPER | -4% | 46.3% | -13.9% | -8% |
RGC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -8.1% | 47.4% | 2.4% | 4% |
| iShares High Yield Corp. Bond | HYG | -7% | 47.5% | -2.7% | -9% |